Sign In
Buy PMVP
$1.16
-0.0200 (-1.69%)
At Close: Jun 03, 2026
PMV Pharmaceuticals Announces Board Chair Transition
08:00am, Wednesday, 22'nd Apr 2026
Rich Heyman to retire from PMV Pharma Board of Directors; Laurie Stelzer, Director since 2020, appointed as new Chair Rich Heyman to retire from PMV Pharma Board of Directors; Laurie Stelzer, Director
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
08:00am, Friday, 06'th Mar 2026
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and developm
PMV Pharmaceuticals (NASDAQ:PMVP) versus Aurinia Pharmaceuticals (NASDAQ:AUPH) Financial Comparison
02:38am, Sunday, 23'rd Nov 2025
Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and PMV Pharmaceuticals (NASDAQ: PMVP - Get Free Report) are both medical companies, but which is the better business? We will contrast the two
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and developme
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 0.7% – Still a Buy?
03:50am, Thursday, 23'rd Oct 2025
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP - Get Free Report)'s stock price traded up 0.7% on Wednesday. The stock traded as high as $1.55 and last traded at $1.54. 686,775 shares were traded during mid-
PRINCETON, N.J., Oct. 13, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and developmen
Small-Cap PMV Pharmaceuticals Cancer Drug Shows Confirmed Responses In 8 Tumor Types
03:10pm, Wednesday, 10'th Sep 2025
PMV Pharmaceuticals, Inc. PMVP on Wednesday released interim data from the Phase 2 pivotal portion of the PYNNACLE clinical trial evaluating rezatapopt in patients with advanced solid tumors harboring
PRINCETON, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and developm
PMV Pharmaceuticals (PMVP) Q2 Loss Jumps
11:39am, Thursday, 07'th Aug 2025
PMV Pharmaceuticals (PMVP) Q2 Loss Jumps
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights
08:42am, Thursday, 07'th Aug 2025
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and developmen
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
04:05pm, Friday, 23'rd May 2025
PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, t
Here's Why PMV Pharmaceuticals (PMVP) Looks Ripe for Bottom Fishing
10:56am, Wednesday, 05'th Mar 2025
PMV Pharmaceuticals (PMVP) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions coul
PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights
08:00am, Monday, 03'rd Mar 2025
Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 90% of si
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
08:00am, Tuesday, 11'th Feb 2025
PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic the
Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher
10:56am, Monday, 03'rd Jun 2024
PMV Pharmaceuticals (PMVP) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement
